BLAVATNIK CENTER for Drug Discovery

Therapeutic Approaches: Small Molecules, Peptides, Image-based HCS analysis, HT qRT-PCR and miRNA microarray assays, Target-structure modeling, Molecular modeling, Structure based drug design

Therapeutic Areas of Expertise: Neurological Disorders, Oncology, Rare Diseases

Center/Program Highlights: The BLAVATNIK CENTER for Drug Discovery (BCDD) is a fully integrated center for translational research, based at Tel Aviv University, that comprises medicinal chemistry, biological target identification and computer-assisted drug design units under one roof. The BCDDs commitment is to provide support for early-stage drug discovery and translating academic innovations into new drug candidates.
The BCDD provides state-of-the-art research environment and academic platform, expertise and and infrastructure to help researchers develop disease models/biological assays for drug screening and to advance promising early-stage drug candidates through the optimization/target validation pipeline.

Sources of Funding: Federal/State, Philanthropy, University


Institutional Affiliation(s): Tel Aviv University

BLAVATNIK CENTER for Drug Discovery
Tel Aviv University
Tel Aviv
Israel, 6997801

Center/Program Start Date: 2016

Number of Employees: 14